Investment to progress RheumaGen’s celiac disease program through early development as a potential transformational gene therapy

AURORA, Colo., Dec. 22, 2025 — RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced that Beyond Celiac Investments (BCI), the venture philanthropy program of Beyond Celiac, has made a Series A-1 preferred stock investment in RheumaGen to advance RheumaGen’s celiac disease program through early development to demonstrate preclinical proof of concept in celiac disease.

“We are incredibly excited about the work RheumaGen is doing in rheumatoid arthritis and the potential to translate that progress and its innovative HLA gene-editing platform to celiac disease,” said Jordan Dubow, M.D., leader of the BCI Investment Committee and Chief Medical Officer at Beyond Celiac. “BCI has a deep due diligence process, and RheumaGen emerged as an outstanding example of the type of company we are looking to support.”

The RheumaGen opportunity was identified through BCI’s inaugural Catalyst Program, which screens for investments in early-stage candidates with the potential for transformational efficacy in celiac disease. Potential candidates from other companies have also emerged from this process which may result in future investments.

“We are grateful to Beyond Celiac Investments for their generous support and conviction in RheumaGen’s novel drug-development approach and experienced team,” said Richard Freed, CEO & Co-Founder of RheumaGen. “Our HLA gene-editing platform has the potential to improve the lives of millions of patients by blocking autoimmune diseases at their source without broad immunosuppression. We are excited about generating proof of concept for patients with celiac disease, who have remained without a curative treatment for far too long.”

BCI has surpassed its first-year fundraising goal and is moving forward with its first investments in companies developing potential treatments for celiac disease. Through its Catalyst Program, BCI will support efforts that show strong potential to advance into clinical trials and ultimately help deliver the first treatments and a cure for celiac disease.

About RheumaGen, Inc.

RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure common autoimmune diseases. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado, and partners with the ClinImmune Center for Clinical Immunology at the University of Colorado Anschutz Medical Campus for clinical development and manufacturing. For more information, please visit rheumagen.com or follow the Company on LinkedIn.

About Beyond Celiac Investments

BCI operates as the venture philanthropy arm of Beyond Celiac, the nonprofit organization leading the effort to accelerate treatments and a cure for celiac disease. For additional information or to learn more about BCI, visit https://www.beyondceliac.org/beyond-celiac-investments/

SOURCE RheumaGen, Inc.

Investment to progress RheumaGen’s celiac disease program through early development as a potential transformational gene therapy

PHILADELPHIA, Dec. 22, 2025 — Beyond Celiac Investments (BCI), the venture philanthropy program of Beyond Celiac, has made a Series A-1 preferred stock investment in RheumaGen, a cell and gene therapy company focused on editing the human leukocyte antigen (HLA) to develop one-time, curative cell and gene therapies for common autoimmune diseases. The investment will be used to advance their celiac disease program through early development to demonstrate preclinical proof of concept in celiac disease.

“We are incredibly excited about the work RheumaGen is doing in rheumatoid arthritis and the potential to translate that progress and its innovative HLA gene-editing platform to celiac disease,” said Jordan Dubow, M.D., leader of the BCI Investment Committee and Chief Medical Officer at Beyond Celiac. “BCI has a deep due diligence process, and RheumaGen emerged as an outstanding example of the type of company we are looking to support.”

The RheumaGen opportunity was identified through BCI’s inaugural Catalyst Program, which screens for investments in early-stage candidates with the potential for transformational efficacy in celiac disease. Potential candidates from other companies have also emerged from this process which may result in future investments.

“We are grateful to Beyond Celiac Investments for their generous support and conviction in RheumaGen’s novel drug-development approach and experienced team,” said Richard Freed, CEO & Co-Founder of RheumaGen. “Our HLA gene-editing platform has the potential to improve the lives of millions of patients by blocking autoimmune diseases at their source without broad immunosuppression. We are excited about generating proof of concept for patients with celiac disease, who have remained without a curative treatment for far too long.”

BCI has surpassed its first-year fundraising goal and is moving forward with its first investments in companies developing potential treatments for celiac disease. Through its Catalyst Program, BCI will support efforts that show strong potential to advance into clinical trials and ultimately help deliver the first treatments and a cure for celiac disease.

About Beyond Celiac Investments:
BCI operates as the venture philanthropy arm of Beyond Celiac, the nonprofit organization leading the effort to accelerate treatments and a cure for celiac disease. For additional information or to learn more about BCI, visit https://www.beyondceliac.org/beyond-celiac-investments/.

About RheumaGen, Inc.:
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure common autoimmune diseases. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado, and partners with the ClinImmune Center for Clinical Immunology at the University of Colorado Anschutz Medical Campus for clinical development and manufacturing. For more information, please visit rheumagen.com or follow the Company on LinkedIn.

SOURCE Beyond Celiac

HONGKONG, 20 december 2025 — ETHGas, een afwikkelingsinfrastructuur voor Ethereum, kondigt het debuut aan van Ethereums Blockspace Futures Market, met US $ 800 miljoen aan verbintenissen van toonaangevende bouwers in Ethereum en een seed-ronde van $ 12 miljoen onder leiding van Polychain Capital.

ETHGas is een afwikkelingsinfrastructuur die de blokruimte van Ethereum verhandelbaar maakt, waardoor gebruikers van Ethereum en gedistribueerde computertoepassingen elk kwantum van berekening en opslag op de blockchain kunnen handelen, verwerven, verkopen en hedgen.

ETHGas pakt de bewerkingsbeperkingen van Ethereum en de volatiliteit van de gasprijs aan door middel van transactiefutures (“voorbevestigingen”) in een hele reeks looptijden en nauwkeurige orderuitvoering. ETHGas stelt Ethereums groothandeldeelnemers in staat om de risico’s binnen de transactiepijplijn te verminderen, de staking-opbrengsten te verhogen en tegelijkertijd de volatiliteit van de gasprijzen voor ondernemingen te verminderen en gaskosten voor consumenten te elimineren.

ETHGas werkt nauw samen met de Ethereum Foundation en volgt Ethereum-medeoprichter Vitalik Buterins  oproep voor een gas futures-markt.

ETHGas viert de komst van Ethereums Blockspace Futures Market en vestigt blockspace als een unieke en verhandelbare activasleutel voor de levensvatbaarheid van proof-of-stake blockchains. ETHGas wordt geleid door Kevin Lepsoe, financieel ingenieur en voormalig hoofd van de afdeling gestructureerde derivaten van Morgan Stanley in Azië. Hij leidt een team van ingenieurs en kwantitatieve ontwikkelaars van Morgan Stanley, Deutsche Bank, HKEx en Lockheed Martin.

De lancering van ETHGas gaat gepaard met de afsluiting van een seed-ronde van $ 12 miljoen onder leiding van Polychain en met opmerkelijke investeerders zoals Stake Capital, BlueYard Capital, Lafayette Macro Advisors, SIG DT en Amber Group, evenals Ethereum-validatoren, blockbouwers en relays. Samen hebben deze partijen een initiële bijdrage van US $ 800 miljoen geleverd in verbintenissen om de marktplaats en productontwikkeling van ETHGas te ondersteunen.

Over ETHGas

ETHGas is een marktplaats voor Ethereum-blockspaceverbintenissen. ETHGas transformeert de manier waarop gebruikers met Ethereum omgaan door lage latentie, afwikkelingstijden van 3 ms en een veelomvattend productpakket dat is gericht op het mogelijk maken van nauwkeurige orderuitvoering. De missie van ETHGas is om Ethereum te bevorderen in een realtime netwerk dat de volgende fase van zijn evolutie ontgrendelt. We stellen ons een toekomst voor waarin eindgebruikers zich kunnen beschermen tegen de volatiliteit van de gasprijs, kansen voor extra opbrengst kunnen ontsluiten en hun ervaring binnen het Ethereum-ecosysteem kunnen verbeteren.

Over Polychain Capital

Polychain Capital is een vooraanstaand beleggingsbedrijf dat zich richt op de blockchain- en cryptocurrencyruimte. Met een missie om de wereldwijde acceptatie van gedecentraliseerde technologieën te bevorderen, ondersteunt Polychain innovatieve projecten die financiën, technologie en betrokkenheid van de gemeenschap herdefiniëren.

Foto – https://mma.prnewswire.com/media/2849668/ETHGas_Seed_Fund.jpg 

HONG KONG, 20. Dezember 2025 — ETHGas, eine Abwicklungsinfrastruktur für Ethereum, kündigt den Start von Ethereums Blockspace-Terminmarkt an, mit Zusagen in Höhe von 800 Millionen US-Dollar von führenden Akteuren im Ethereum-Ökosystem sowie einer von Polychain Capital geleiteten Seed-Runde über 12 Millionen US-Dollar.

ETHGas ist eine Abwicklungsinfrastruktur, die den Ethereum-Blockspace handelbar macht und es Nutzern von Ethereum sowie verteilten Rechenanwendungen ermöglicht, beliebige Mengen an Rechenleistung und Speicherplatz auf der Blockchain zu handeln, zu erwerben, weiterzuverkaufen und abzusichern.

ETHGas begegnet den Verarbeitungsbeschränkungen von Ethereum sowie der Volatilität der Gaspreise durch Transaktionsfutures („Vorbestätigungen”) über verschiedene Laufzeiten hinweg und durch eine präzise Auftragsausführung. ETHGas hilft institutionellen Teilnehmern im Ethereum-Markt, Risiken innerhalb der Transaktionspipeline zu reduzieren, Staking-Erträge zu erhöhen, die Volatilität der Gaspreise für Unternehmen zu verringern sowie Gasgebühren für Verbraucher zu eliminieren.

ETHGas arbeitet in enger Abstimmung mit der Ethereum Foundation und folgt dem Aufruf von Ethereum-Mitbegründer Vitalik Buterin für einen Gas-Terminmarkt.

ETHGas markiert den Beginn von Ethereums Blockspace-Terminmärkten und etabliert Blockspace als einzigartigen, handelbaren Vermögenswert, der für die Lebensfähigkeit von Proof-of-Stake-Blockchains entscheidend ist. ETHGas wird von Kevin Lepsoe geleitet, einem Finanzingenieur und ehemaligen Leiter des Geschäftsbereichs strukturierte Derivate von Morgan Stanley in Asien. Er leitet ein Team von Ingenieuren sowie Quant-Entwicklern, die von Morgan Stanley, Deutsche Bank, HKEx und Lockheed Martin kommen.

Der Start von ETHGas geht mit dem Abschluss einer Seed-Runde über 12 Millionen US-Dollar einher, die unter Führung von Polychain erfolgt und an der sich namhafte Investoren wie Stake Capital, BlueYard Capital, Lafayette Macro Advisors, SIG DT und Amber Group sowie Ethereum-Validierer, Block-Builder und Relays beteiligen. Zusammen haben diese Parteien zunächst 800 Millionen US-Dollar an Zusagen zur Unterstützung des Marktes und der Produktentwicklung von ETHGas beigesteuert.

Informationen zu ETHGas

ETHGas ist ein Marktplatz für Ethereum-Blockspace-Zusagen. ETHGas verändert die Art und Weise, wie Nutzer mit Ethereum interagieren, indem es niedrige Latenzzeiten, Abwicklungszeiten von 3 ms sowie eine umfassende Produktpalette mit Schwerpunkt auf präziser Auftragsausführung ermöglicht. ETHGas hat es sich zur Aufgabe gemacht, Ethereum zu einem Echtzeit-Netzwerk weiterzuentwickeln, das die nächste Stufe seiner Entwicklung freischaltet. Wir stellen uns eine Zukunft vor, in der Endnutzer sich vor der Volatilität der Gaspreise schützen, Möglichkeiten für zusätzliche Erträge erschließen und ihre Erfahrungen mit dem Ethereum-Ökosystem verbessern können.

Informationen zu Polychain Capital

Polychain Capital ist eine führende Investmentfirma, die sich auf den Bereich Blockchain und Kryptowährungen konzentriert. Mit dem Ziel, die weltweite Einführung dezentraler Technologien voranzutreiben, unterstützt Polychain innovative Projekte, um die Bereiche Finanzen, Technologie und gesellschaftliches Engagement neu zu definieren.

Foto – https://mma.prnewswire.com/media/2849668/ETHGas_Seed_Fund.jpg 

HONG KONG, 20 décembre 2025 — ETHGas, une infrastructure de règlement pour Ethereum, annonce les débuts du marché à terme de l’espace de blocage d’Ethereum, avec 800 millions de dollars d’engagements de la part des principaux constructeurs d’Ethereum et un tour d’amorçage de 12 millions de dollars mené par Polychain Capital.

ETHGas est une infrastructure de règlement qui rend l’espace de blocage d’Ethereum négociable, permettant aux utilisateurs d’Ethereum et d’applications informatiques distribuées de négocier, d’acquérir, de vendre à terme et de couvrir tout quantum informatique et de stockage sur la blockchain.

ETHGas répond aux contraintes de traitement d’Ethereum et à la volatilité des prix du gaz, grâce à des transactions à terme (“pré-confirmations”) sur une gamme d’échéances et à une exécution précise des ordres. ETHGas permet aux participants au marché de gros d’Ethereum de réduire les risques au sein du pipeline de transactions, d’améliorer les rendements de mise, tout en réduisant la volatilité des prix du gaz pour les entreprises et en éliminant les frais de gaz auprès des consommateurs.

ETHGas travaille en étroite collaboration avec la Fondation Ethereum et suit l’appel du cofondateur d’Ethereum, Vitalik Buterin, , en faveur d’un marché à terme du gaz.

ETHGas marque l’avènement des marchés à terme de l’espace de blocage d’Ethereum et établit l’espace de blocage comme actif unique et négociable, essentiel à la viabilité des preuves de participation des blockchains. ETHGas est dirigée par Kevin Lepsoe, ingénieur financier et ancien responsable des activités de Morgan Stanley dans le domaine des produits dérivés structurés en Asie. Il dirige une équipe d’ingénieurs et de développeurs quantitatifs issus de  Morgan Stanley, Deutsche Bank, HKEx et Lockheed Martin.

Le lancement d’ETHGas s’accompagne de la clôture d’un tour de table de 12 millions de dollars mené par Polychain et auquel participent des investisseurs de renom tels que Stake Capital, BlueYard Capital, Lafayette Macro Advisors, SIG DT et Amber Group, ainsi que des validateurs, des constructeurs de blocs et des relais Ethereum. Ensemble, ces parties ont pris des engagements d’un montant initial de 800 millions de dollars pour soutenir le marché d’ETHGas et le développement de ses produits.

À propos d’ETHGas

ETHGas est un marché pour les engagements de l’espace de blocage Ethereum. ETHGas transforme la façon dont les utilisateurs interagissent avec Ethereum en permettant une faible latence, des délais de règlement de 3 ms et une gamme complète de produits centrés sur l’exécution précise des ordres. La mission d’ETHGas est de faire évoluer Ethereum vers un réseau en temps réel qui entamera la prochaine étape de son évolution. Nous envisageons un avenir où les utilisateurs finaux pourront se protéger de la volatilité du prix du gaz, libérer des possibilités de rendement supplémentaire et améliorer leur expérience au sein de l’écosystème Ethereum.

À propos de Polychain Capital

Polychain Capital est une société d’investissement de premier plan axée sur la blockchain et les crypto-monnaies. Avec pour mission de faire progresser l’adoption mondiale des technologies décentralisées, Polychain soutient des projets innovants qui redéfinissent la finance, la technologie et l’engagement communautaire.

Photo – https://mma.prnewswire.com/media/2849668/ETHGas_Seed_Fund.jpg 

BEIJING, Dec. 19, 2025 — Galbot has successfully completed a new funding round exceeding $300 million, bringing the company’s total funding to $800 million. This round once again sets new records for both the largest single-round financing and cumulative financing in the embodied AI sector, further cementing Galbot’s leadership in the rapidly evolving field of embodied AI and humanoid robotics.

The financing round attracted significant investors from China, Singapore, and the Middle East, underscoring global confidence in Galbot’s cutting-edge technology. With this investment, the company’s valuation has reached $3 billion, reflecting its strong market position and the continued faith in its growth prospects.

Leading the Charge in Embodied AI Innovation

Galbot is the world’s first company to fully achieve full-stack in-house development across hundreds-of-billion-scale high-quality datasets,  embodied foundation models, and robotic hardware. This groundbreaking approach has positioned Galbot as a global leader in the embodied intelligence field. The company’s self-developed key technologies, including its embodied intelligence large models, have pioneered global firsts in areas such as multi-task generalization, whole-body motion control, cross-embodiment autonomous navigation, and dexterous hand manipulation. These innovations have laid a solid technological foundation for the large-scale deployment of humanoid robots.

Commercializing Embodied Intelligence Across Industries

Galbot has already achieved remarkable success in deploying humanoid robots at scale across various industries:

• Industrial Manufacturing: Galbot has partnered with leading companies such as CATL, Bosch, Toyota, and Hyundai, becoming the first company globally to deploy humanoid robots for real autonomous operations on manufacturing floors. With these advancements, Galbot has secured orders for thousands of units, demonstrating the scalability and reliability of its humanoid robots in real-world industrial applications.
• Smart City Service: Galbot has launched Galbot Store, a fully autonomous retail solution powered entirely by Galbot G1 robots. Currently operational in over 30 cities nationwide, Galbot Store is revolutionizing the smart retail and city service sectors by offering customers a unique and seamless interaction experience.
• Warehouse Logistics: Galbot’s autonomous warehouse solutions are deployed in multiple locations, demonstrating stable and continuous 24/7 operations for over a year. These solutions are addressing critical operational challenges, enhancing efficiency and meeting the growing demands of the retail logistics industry.
• Healthcare: In collaboration with leading hospitals like Xuanwu Hospital, Galbot is deploying humanoid robots to assist in patient rooms, pharmacies, and hospital guidance systems. These robots are improving patient care while helping streamline hospital operations and enhance overall efficiency.

With this new investment, Galbot is positioned to accelerate its technology development, scale its deployments, and expand its global reach. The company remains committed to advancing embodied AI technology, bringing innovation to new sectors, and strengthening its position as a leader in the global robotics market.

About Galbot

Beijing Galbot AI Co., Ltd. is a global pioneer in embodied AI and general-purpose robotics. With R&D centers in Beijing, Shenzhen, Suzhou, and Hong Kong, Galbot brings together world-class scientists and engineers with decades of experience in embodied intelligence and robotics. Its flagship product, the Galbot G1, has been widely deployed in manufacturing, logistics, retail, and healthcare, achieving over one year of proven and stable real-world operations.

As an industry leader, Galbot is driving continuous innovation in embodied AI and accelerating the industrial deployment of autonomous, general-purpose humanoid robots worldwide.

SOURCE Beijing Galbot AI Co., Ltd.

STAMFORD, Conn., Dec. 19, 2025 — Steward Partners, an employee-owned independent financial services firm specializing in comprehensive wealth management solutions, today announced that it has raised $475 million in strategic capital from Ares Credit funds (“Ares”), comprising a significant expansion of its lending relationship and a non-controlling minority investment. Ares joins Steward Partners’ existing institutional partners, Cynosure Group (“Cynosure”) and The Pritzker Organization (“TPO”), in backing the firm. Strategic direction and day-to-day decision-making remain with Steward Partners’ leadership and partners.

From its humble beginnings over 12 years ago with three advisors and under $100 million in assets, Steward Partners has grown into a national powerhouse built on advisor independence, employee ownership, and a relentlessly client-focused culture. Today, with nearly $50 billion in client assets and a thriving partner-led model, the firm combines scale with the agility and entrepreneurial spirit of a boutique platform.

Underpinning this growth is the distinctive ownership model—partners who build the business have meaningful equity stakes in its success. This structure drives accountability, long-term decision-making, and deep alignment between advisors, employees, and clients, creating a firm in which those who serve clients are also invested owners building for the long term. 

“This is another defining milestone for Steward Partners,” said Jim Gold, Chief Executive Officer of Steward Partners. “This transaction is a strong affirmation of everything our partners have built over more than a decade. Our team has created meaningful value through years of deep commitment to our mission, and we are thrilled to see the commitment of our partners rewarded.”

“We weren’t looking for capital alone, we were looking for alignment, vision, and partnership,” added Hy Saporta, President & Chief Operating Officer of Steward Partners. “Ares stood out because they respect independence, understand collaboration, and support our long-term vision. This structure preserves everything that makes Steward Partners special.”

“Ares is pleased to provide flexible capital to support Steward Partners in its next phase of growth, and this transaction reflects our confidence in the company’s leadership and market position,” said Scott Rosen, Partner in Ares Credit. “We’re proud to work with a company that has deep alignment across employees, management and investors.” 

Keith Taylor, Board Chairman of Steward Partners, remarked, “Jim and Hy had a vision for creating an exceptional, employee-owned, advisory firm and, importantly, one that also distributed cash flow to the employee owners in both profit-sharing as well as Capital events. This is a terrific way to recognize and reward Partners for their contributions. Cynosure’s investment in 2019 was the first of what is now three investments that strengthen Steward and return money to employee owners. I know I speak for TPO as well when I say that the Company performance thus far has been amazing, but the best is yet to come and we are excited to remain invested for that future.”

Jason Sussman, of TPO, commented, “Steward has redefined what a partnership model can look like in wealth management, and they have sustained it at scale. We look forward to the next leg of growth.”

Saporta concluded, “We’re extremely proud of what we’ve built, we’re grateful to the partners who got us here, and we’re beyond energized by the opportunities that lay ahead as we continue building a firm that is durable, independent, and truly differentiated in the wealth management space.”

Since its launch in 2013, Steward Partners has solidified its place as one of the industry’s fastest-growing and most influential RIA firms. The firm was recently recognized with a #9 ranking on the 2025 Barron’s Top 100 RIA Firms list, up from its #18 ranking in 2024. Additionally, Steward Partners was named a 2025 Thrivent Employer of Choice by InvestmentNews, reflecting the firm’s commitment to fostering a collaborative, partner-drive culture. Several Steward Partners advisors and teams were also honored on Forbes | SHOOK’s 2025 Best-In-State Wealth Advisors and Best-In-State Wealth Management Teams lists, underscoring the quality of client service delivered across the platform. Please visit Important Disclosures at www.stewardpartners.com for more information regarding these awards.

Piper Sandler & Co. served as the exclusive financial advisor to Steward Partners. Ropes & Gray LLP and Latham & Watkins served as legal counsel to Steward Partners. Cahill Gordon & Reindel LLP served as legal counsel to Ares.

About Steward Partners
Representing some of the U.S.’s top advisors, Steward Partners is a full-service, employee-owned, independent financial services firm that offers wealth management solutions for families, businesses, and multigenerational investors. Established in 2013, the firm fosters a positive, transparent culture of camaraderie and excellence that has fueled its substantial growth in a highly competitive industry. Offering services such as comprehensive wealth planning, private banking, institutional consulting, and business solutions, the firm was responsible for nearly $50 billion in client assets as of December 2025.

To learn more about Steward Partners, visit www.stewardpartners.com.

About Ares Management Corporation
Ares Management Corporation is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, real estate, private equity and infrastructure asset classes. We seek to advance our stakeholders’ long-term goals by providing flexible capital that supports businesses and creates value for our investors and within our communities. By collaborating across our investment groups, we aim to generate consistent and attractive investment returns throughout market cycles. As of September 30, 2025, Ares Management Corporation’s global platform had over $595 billion of assets under management, with operations across North America, South America, Europe, Asia Pacific and the Middle East. For more information, please visit www.aresmgmt.com.

Media Contact:
Zach Allegretti
JConnelly
[email protected]
973-850-7341

SOURCE Steward Partners

MIAMI, Dec. 19, 2025 — Beycome, a tech-first, direct-to-consumer real estate platform, today announced it has raised $2.5 million in seed funding. Founded in 2020, Beycome has helped its users complete nearly 20,000 home transactions, closing roughly one home every 40 minutes, saving more than $215 million in fees.

The round is led by InsurTech Fund, with participation from Pivot Ventures, the Florida Opportunity Fund, RedShift Capital, Neer Venture Capital, Kima Ventures, Ignite Venture, and Founders Future, and several highly strategic investors and angels. These new investors bring deep expertise across real estate, insurance, fintech, and digital innovation.

The financing comes at a time when home affordability is near all-time lows, resulting in more homeowners and buyers seeking options offering greater savings, control and transparency without sacrificing pricing and support.

Beycome was built to support that shift, not to replace agents, but to give people more choice in how they sell, buy, and close their real estate, all within one platform.

“After bootstrapping Beycome for 3 years and reaching profitability, this capital allows us to move faster,” said Nico Jodin, CEO and co-founder of Beycome. “With the right partners now on board, we can accelerate product development, strengthen our technical leadership, and expand into many more states.”

Beycome enables people to sell, buy and close on their own terms through a flat-fee model. Instead of paying a percentage-based commission, users choose a clear, upfront fee from $99 to $999 and gain access to powerful digital tools, backed by experienced professionals.

At the core of the platform is Beycome‘s proprietary AI system, Artur. Artur supports users throughout the entire transaction lifecycle, from pricing and market exposure to offer management, paperwork, closing coordination, title services, and buying their next home. By automating complexity and guiding decisions in real time, Artur helps users move forward with greater speed, clarity, and confidence.

“We backed Beycome because they merge human expertise and AI to truly improve the home selling experience,” said David Gritz, Managing Director at InsurTech Fund. “There’s been a lot of AI hype in insurance and real estate, but what stood out here was the real-world impact and results already delivered. Artur isn’t theoretical — it actively helps sell thousands of homes, simplifies transactions, reduces costs, and guides people all the way to settlement, where Beycome’s title agency takes over. It already works for everyone, from first-time sellers to seasoned investors, builders, flippers, and everyday homeowners.”

The new capital will enable Beycome to further deepen its AI capabilities, expand nationwide, scale its title services and buyer-focused programs, and continue building a fully integrated real estate ecosystem. It will also support the recruitment of top talent and strategic partners aligned with Beycome’s mission to modernize real estate through technology and transparency.

Real estate does not need a single path forward. It needs more options.

Beycome is building those options, helping users keep more of their equity while gaining clarity, control, and real choice in one of the most important financial decisions of their lives.

About Beycome

Beycome is a Miami-based real estate technology company offering a direct-to-consumer platform that enables homeowners and buyers to sell, buy, and close real estate transactions on their own terms. Through flat-fee pricing, AI-powered guidance, and integrated title services, Beycome has helped their users complete 18,500+ transactions while saving more than $215 million in fees.

For more information, visit beycome.com.

Contact:
[email protected]
***@beycome.com

Photos:
https://www.prlog.org/13117446

Press release distributed by PRLog

SOURCE Beycome Corp.

BENGALURU, India, Dec. 19, 2025 — LatentForce, an AI-native platform for large-scale enterprise code migrations and software modernisation, has raised $1.7M in a Seed round co-led by Ideaspring Capital and Yali Capital. The funding will strengthen its proprietary migration models and accelerate expansion across India and globally. Founded in 2024, LatentForce is building an agentic AI platform for enterprise code migrations and software overhauls, a market estimated at US$22.7 billion today and projected to exceed US$50 billion by 2031.

While most AI coding tools focus on individual developers, LatentForce builds specialised AI systems for large-scale enterprise modernisation. Using task-specific Small Language Models (SLMs) purpose-built for legacy transformation, the platform enables organisations to upgrade decades-old software with greater accuracy, security, and control, reducing migration cost, risk, and time by up to 80%.

Aravind Jayendran, Founder and CEO of LatentForce, said, “Most enterprises are constrained by decades of technical debt. Code migration is not just a coding problem but a system transformation challenge. At LatentForce, we are building the default enterprise platform to eliminate legacy tech debt through AI-driven modernisation.”

Reflecting on the philosophy behind modernisation, Prathosh A P, Assistant Professor at IISc Bangalore and Co-founder of LatentForce, incubated at FSID, IISc, said, “Modernisation is not just rewriting code; it is continuity of intent—carrying forward the wisdom of the past into the architecture of the future without distortion.”

Speaking on execution at scale, Vinay Kyatham, Co-founder and CTO of LatentForce, said, “Enterprise migration projects fail not due to lack of intent, but loss of engineering control at scale. LatentForce provides deterministic pipelines, security by design, and modernises mission-critical systems with confidence rather than guesswork.”

“Ideaspring Capital is excited to back LatentForce, whose vertically integrated AI platform combines custom LLMs with deep graph engines to drive a paradigm shift in the $5 trillion legacy code market. With enterprises demanding control and compliance, LatentForce’s audit-ready approach enables reliable, non-mainframe migrations at scale,” said Naganand Doraswamy, Managing Partner, Ideaspring Capital.

Ganapathy Subramaniam of Yali Capital, said, “AI-first deep tech is central to Yali’s investment thesis, and LatentForce exemplifies how specialised systems can deliver at enterprise scale. Aravind, Vinay, and Prathosh bring deep expertise in applied research and engineering, and we’re excited to partner with them as they scale this category-defining technology.”

Photo: https://mma.prnewswire.com/media/2849672/LATENTFORCE_Founders.jpg

SOURCE LatentForce Intelligence